US Equity
CRNX
— CRINETICS PHARMACEUTICALS, INC.Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing therapies for rare endocrine diseases and endocrine-related tumors.
💰 Market cap: $8.87B📍 6055 Lusk Blvd., SAN DIEGO, CA, 92121 US🏷️ Biotechnology & Medical Research💵 Previous close: $83.73🔢 7,468 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $83.73 |
| 2026-07-23 | $83.65 |
| 2026-07-22 | $83.72 |
| 2026-07-21 | $83.90 |
| 2026-07-20 | $83.87 |
| 2026-07-17 | $83.86 |
| 2026-07-16 | $83.91 |
| 2026-07-15 | $83.90 |
| 2026-07-14 | $83.71 |
| 2026-07-13 | $83.67 |
| 2026-07-10 | $83.58 |
| 2026-07-09 | $83.62 |
| 2026-07-08 | $83.49 |
| 2026-07-07 | $83.53 |
| 2026-07-06 | $42.03 |
| 2026-07-02 | $42.23 |
| 2026-07-01 | $38.68 |
| 2026-06-30 | $37.42 |
| 2026-06-29 | $36.94 |
| 2026-06-26 | $36.70 |
| 2026-06-25 | $34.99 |
| 2026-06-24 | $36.18 |
| 2026-06-23 | $35.91 |
| 2026-06-22 | $35.38 |
| 2026-06-18 | $35.87 |
| 2026-06-17 | $35.75 |
| 2026-06-16 | $35.00 |
| 2026-06-15 | $35.12 |
| 2026-06-12 | $34.47 |
| 2026-06-11 | $33.53 |
| 2026-06-10 | $34.32 |
| 2026-06-09 | $34.97 |
| 2026-06-08 | $33.48 |
| 2026-06-05 | $32.92 |
| 2026-06-04 | $34.63 |
| 2026-06-03 | $33.09 |
| 2026-06-02 | $32.61 |
| 2026-06-01 | $34.52 |
| 2026-05-29 | $35.55 |
| 2026-05-28 | $36.01 |
| 2026-05-27 | $36.79 |
| 2026-05-26 | $36.78 |
| 2026-05-22 | $36.80 |
| 2026-05-21 | $37.09 |
| 2026-05-20 | $36.27 |
| 2026-05-19 | $34.94 |
| 2026-05-18 | $34.70 |
| 2026-05-15 | $36.77 |
| 2026-05-14 | $38.31 |
| 2026-05-13 | $37.48 |
| 2026-05-12 | $36.91 |
| 2026-05-11 | $36.55 |
| 2026-05-08 | $37.48 |
| 2026-05-07 | $43.49 |
| 2026-05-06 | $41.71 |
| 2026-05-05 | $40.75 |
| 2026-05-04 | $41.25 |
| 2026-05-01 | $39.02 |
| 2026-04-30 | $38.78 |
| 2026-04-29 | $38.44 |
| 2026-04-28 | $38.15 |